Abstract
The advancements in nuclear imaging techniques significantly impact the management of cardiac amyloidosis. These methods allow for a more accurate diagnosis, detailed assessment of disease extent, and better differentiation between amyloidosis types, which are crucial for tailoring treatment approaches. The integration of these techniques into clinical practice is essential for improving patient outcomes and advancing research in cardiac amyloidosis.
Original language | English (US) |
---|---|
Journal | Current Opinion in Cardiology |
DOIs | |
State | Accepted/In press - 2024 |
Keywords
- PET
- PYP
- cardiac amyloidosis
- cardiac scintigraphy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine